Advertisement

Topics

Motus GI Bolsters Medical Advisory Board with Appointment of Seth A. Gross, MD, FACG, FASGE, AGAF

08:05 EDT 16 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
– Dr. Gross to serve as principal investigator in Company’s REDUCE Study of the Pure-Vu® System for in-patient colonoscopy, on track to commence in Q2 2018 – Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Mot...

Other Sources for this Article

Motus GI Holdings, Inc.
Investors:
Jenene Thomas Communications, LLC
Jenene Thomas, 833-475-8247
mots@jtcir.com
or
Media:
6 Degrees PR
Tony Plohoros, 908-940-0135
tplohoros@6degreesPR.com

NEXT ARTICLE

More From BioPortfolio on "Motus GI Bolsters Medical Advisory Board with Appointment of Seth A. Gross, MD, FACG, FASGE, AGAF"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...